![]() |
|
![]() |
||||
Thread | Thread Starter | Forum | Replies | Last Post |
Finding CNVs in tumors, no control, WES - Which programs should I use? | Miau | Bioinformatics | 0 | 08-01-2014 03:06 AM |
NGS whole genome sequence versus sequence capture for quality control | houkto | Bioinformatics | 0 | 02-02-2012 05:16 AM |
PubMed: Control-free calling of copy number alterations in deep-sequencing data using | Newsbot! | Literature Watch | 0 | 04-08-2011 02:10 AM |
Sequence Alignment Quality Control | nilshomer | Bioinformatics | 4 | 02-06-2010 08:24 AM |
![]() |
|
Thread Tools |
![]() |
#1 |
Junior Member
Location: South Central US Join Date: Aug 2012
Posts: 7
|
![]()
Hello Seqers,
we currently do WES with a mean coverage of ~120x for tumor as well as the germline samples. Since we only use the germline to help us with the somatic alteration calls I was thinking about cutting the coverage of the germline samples in half to free up some real estate on the flowcell. Does any one have experience with this? Thanks, O. |
![]() |
![]() |
![]() |
#2 |
Senior Member
Location: UK Join Date: Jan 2010
Posts: 390
|
![]()
We'd normally do 50x on the normal and 100x+ on the tumour - I think that's quite a common strategy.
|
![]() |
![]() |
![]() |
#3 |
Member
Location: USA Join Date: Aug 2013
Posts: 52
|
![]()
It depends on your downstream processes. If you are simply calling SNVs then it doesn't really matter. But for other applications (eg. CNVs), many programs prefer to have similar coverage between your tumor and normal. Even if they don't require it, you are getting rid of other sources of variation (eg. by capturing the same amount of DNA in the same exome hyb reaction).
|
![]() |
![]() |
![]() |
Tags |
coverage depth, germline, illumina, wes |
Thread Tools | |
|
|